Early-stage cancer results in a multiplicative increase in cell-free DNA originating from healthy tissue
{{output}}
Cell-free DNA (cfDNA) is a promising biomarker for cancer detection. However, the sources of elevated cfDNA in patients with early-stage cancer, and the mechanisms by which cfDNA is shed into, and subsequently cleared from the circulation are still poorly unde... ...
